| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
17,237 |
15,133 |
$800K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,982 |
5,422 |
$196K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,448 |
1,399 |
$157K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
4,083 |
1,531 |
$139K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,376 |
1,315 |
$118K |
| 99233 |
Prolong inpt eval add15 m |
2,081 |
583 |
$81K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
1,447 |
230 |
$39K |
| 99223 |
Prolong inpt eval add15 m |
660 |
564 |
$38K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
5,020 |
4,562 |
$35K |
| 99401 |
|
1,436 |
1,234 |
$32K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
3,022 |
2,925 |
$26K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
2,365 |
2,065 |
$24K |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
3,987 |
3,664 |
$22K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
449 |
380 |
$16K |
| 99306 |
Prolong nursin fac eval 15m |
292 |
257 |
$16K |
| 90674 |
|
607 |
600 |
$11K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
724 |
710 |
$9K |
| 90756 |
|
359 |
337 |
$7K |
| 93922 |
|
233 |
230 |
$6K |
| 93000 |
|
496 |
483 |
$6K |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
420 |
366 |
$3K |
| 90661 |
|
88 |
88 |
$1K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
1,188 |
1,029 |
$1K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
16 |
16 |
$1K |
| 99422 |
|
55 |
53 |
$731.46 |
| G0008 |
Administration of influenza virus vaccine |
297 |
289 |
$694.35 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
471 |
389 |
$530.69 |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
18 |
14 |
$327.00 |
| 99406 |
|
41 |
41 |
$262.47 |
| 3008F |
|
15,660 |
13,601 |
$90.00 |
| 93880 |
|
17 |
13 |
$84.00 |
| 3080F |
|
1,023 |
961 |
$0.00 |
| G8755 |
Most recent diastolic blood pressure >= 90 mmhg |
1,966 |
1,738 |
$0.00 |
| 3074F |
|
3,552 |
3,133 |
$0.00 |
| 3079F |
|
2,193 |
2,007 |
$0.00 |
| 3075F |
|
1,547 |
1,451 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
3,475 |
2,990 |
$0.00 |
| 1036F |
|
3,140 |
2,988 |
$0.00 |
| 3014F |
|
118 |
108 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
71 |
66 |
$0.00 |
| G9231 |
Documentation of end stage renal disease (esrd), dialysis, renal transplant before or during the measurement period or pregnancy during the measurement period |
103 |
39 |
$0.00 |
| 3017F |
|
42 |
40 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
18,411 |
15,969 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
3,603 |
3,056 |
$0.00 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
1,742 |
1,557 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
403 |
358 |
$0.00 |
| 3078F |
|
3,321 |
2,943 |
$0.00 |
| 3077F |
|
1,435 |
1,339 |
$0.00 |
| 4004F |
|
147 |
143 |
$0.00 |
| 4040F |
|
47 |
40 |
$0.00 |
| 99072 |
|
845 |
747 |
$0.00 |
| G0030 |
Patient screened for tobacco use and received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling, pharmacotherapy, or both), if identified as a tobacco user |
21 |
21 |
$0.00 |